Harnessing system models of cell death signalling for cytotoxic chemotherapy: towards personalised medicine approaches?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Harnessing system models of cell death signalling for cytotoxic chemotherapy: towards personalised medicine approaches?
Authors
Keywords
MOMP, Cytotoxic chemotherapy, Apoptosis, Systems modelling, Personalised oncology, Molecular medicine
Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 92, Issue 3, Pages 227-237
Publisher
Springer Nature
Online
2014-01-29
DOI
10.1007/s00109-014-1126-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abstract LB-406: Phase 1 study of the Smac mimetic TL32711 in adult subjects with advanced solid tumors and lymphoma to evaluate safety, pharmacokinetics, pharmacodynamics, and antitumor activity
- (2014) R. K. Amaravadi et al. CANCER RESEARCH
- A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma
- (2013) Maria T. Petrucci et al. BRITISH JOURNAL OF HAEMATOLOGY
- Systems Analysis of BCL2 Protein Family Interactions Establishes a Model to Predict Responses to Chemotherapy
- (2013) A. U. Lindner et al. CANCER RESEARCH
- Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approach
- (2013) Á C Murphy et al. Cell Death & Disease
- Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia
- (2012) M. S. Davids et al. BLOOD
- Cancer gene therapy targeting cellular apoptosis machinery
- (2012) Lin-Tao Jia et al. CANCER TREATMENT REVIEWS
- Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML
- (2012) Thanh-Trang Vo et al. CELL
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d’Etude des Lymphomes de l’Adulte (GELA)
- (2012) Vincent Ribrag et al. EUROPEAN JOURNAL OF CANCER
- The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome
- (2012) Maximilian L. Würstle et al. EXPERIMENTAL CELL RESEARCH
- Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer
- (2012) Matthew S. Davids et al. JOURNAL OF CLINICAL ONCOLOGY
- A structured approach to the study of metabolic control principles in intact and impaired mitochondria
- (2012) Heinrich J. Huber et al. Molecular BioSystems
- TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies
- (2012) C. T. Hellwig et al. MOLECULAR CANCER THERAPEUTICS
- A Death Effector Domain Chain DISC Model Reveals a Crucial Role for Caspase-8 Chain Assembly in Mediating Apoptotic Cell Death
- (2012) Laura S. Dickens et al. MOLECULAR CELL
- Stoichiometry of the CD95 Death-Inducing Signaling Complex: Experimental and Modeling Evidence for a Death Effector Domain Chain Model
- (2012) Kolja Schleich et al. MOLECULAR CELL
- Targeting IAP proteins for therapeutic intervention in cancer
- (2012) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Exploring the Contextual Sensitivity of Factors that Determine Cell-to-Cell Variability in Receptor-Mediated Apoptosis
- (2012) Suzanne Gaudet et al. PLoS Computational Biology
- Mitochondrial outer membrane permeabilization during apoptosis: The role of mitochondrial fission
- (2011) Thomas Landes et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Heterogeneity reduces sensitivity of cell death for TNF-Stimuli
- (2011) Monica Schliemann et al. BMC Systems Biology
- Measuring and Modeling Apoptosis in Single Cells
- (2011) Sabrina L. Spencer et al. CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Systems Biology of Apoptosis and Survival: Implications for Drug Development
- (2011) Salvatore Pezzino et al. CURRENT PHARMACEUTICAL DESIGN
- Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases
- (2011) Andreas Strasser et al. EMBO JOURNAL
- Clinical application of a systems model of apoptosis execution for the prediction of colorectal cancer therapy responses and personalisation of therapy
- (2011) Suzanne Hector et al. GUT
- Double-Blind, Placebo-Controlled, Randomized Phase 2 Study of the Proapoptotic Agent AT-101 Plus Docetaxel, in Second-Line Non-small Cell Lung Cancer
- (2011) Neal Ready et al. Journal of Thoracic Oncology
- A Phase II Study of AT-101 (Gossypol) in Chemotherapy-Sensitive Recurrent Extensive-Stage Small Cell Lung Cancer
- (2011) Maria Q. Baggstrom et al. Journal of Thoracic Oncology
- A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer
- (2011) Paul K. Paik et al. LUNG CANCER
- A Unified Model of Mammalian BCL-2 Protein Family Interactions at the Mitochondria
- (2011) Fabien Llambi et al. MOLECULAR CELL
- Glucose metabolism determines resistance of cancer cells to bioenergetic crisis after cytochrome-c release
- (2011) H. J. Huber et al. Molecular Systems Biology
- Lyapunov exponents and phase diagrams reveal multi-factorial control over TRAIL-induced apoptosis
- (2011) B. B. Aldridge et al. Molecular Systems Biology
- Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
- (2011) T. N. Chonghaile et al. SCIENCE
- Caspase-8 activity has an essential role in CD95/Fas-mediated MAPK activation
- (2011) A M M Kober et al. Cell Death & Disease
- Approaches for targeting mitochondria in cancer therapy
- (2010) Gerard G.M. D'Souza et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Mathematical modelling of the mitochondrial apoptosis pathway
- (2010) Heinrich J. Huber et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Diffusion is capable of translating anisotropic apoptosis initiation into a homogeneous execution of cell death
- (2010) Heinrich J Huber et al. BMC Systems Biology
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting mitochondria for cancer therapy
- (2010) David M. Hockenbery ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- The Caspase-8 Dimerization/Dissociation Balance Is a Highly Potent Regulator of Caspase-8, -3, -6 Signaling
- (2010) Maximilian L. Würstle et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL
- (2010) Nicolai Fricker et al. JOURNAL OF CELL BIOLOGY
- Phase I/II Study of AT-101 with Topotecan in Relapsed and Refractory Small Cell Lung Cancer
- (2010) Rebecca Suk Heist et al. Journal of Thoracic Oncology
- The BCL-2 Family Reunion
- (2010) Jerry E. Chipuk et al. MOLECULAR CELL
- Dynamics within the CD95 death-inducing signaling complex decide life and death of cells
- (2010) Leo Neumann et al. Molecular Systems Biology
- Targeting mitochondria for cancer therapy
- (2010) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Mitochondria and cell death: outer membrane permeabilization and beyond
- (2010) Stephen W. G. Tait et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Systems biology analysis of programmed cell death
- (2010) Shani Bialik et al. TRENDS IN BIOCHEMICAL SCIENCES
- A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers
- (2010) Bryan T. Hennessy et al. Clinical Proteomics
- Dynamics of outer mitochondrial membrane permeabilization during apoptosis
- (2009) M Rehm et al. CELL DEATH AND DIFFERENTIATION
- An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer
- (2009) G. Liu et al. CLINICAL CANCER RESEARCH
- Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
- (2009) M. H. Kang et al. CLINICAL CANCER RESEARCH
- Expression of X-linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis
- (2009) Xiang Guoan et al. JOURNAL OF SURGICAL ONCOLOGY
- Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis
- (2009) Sabrina L. Spencer et al. NATURE
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intracellular signaling dynamics during apoptosis execution in the presence or absence of X-linked-inhibitor-of-apoptosis-protein
- (2008) Carla L. O'Connor et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Quantitative Analysis of Pathways Controlling Extrinsic Apoptosis in Single Cells
- (2008) John G. Albeck et al. MOLECULAR CELL
- BCL-2 family antagonists for cancer therapy
- (2008) Guillaume Lessene et al. NATURE REVIEWS DRUG DISCOVERY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modeling a Snap-Action, Variable-Delay Switch Controlling Extrinsic Cell Death
- (2008) John G Albeck et al. PLOS BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now